ReoPro

ReoPro

 
trademark for a preparation of abciximab, an antithrombotic agent.

ReoPro

(rē′ō-prō′)
A trademark for the drug abciximab.

ReoPro

a trademark for a preparation of an antithrombotic agent (abciximab).

ReoPro®

Abciximab, see there.

Reopro

A brand name for the drug ABCIXIMAB.
References in periodicals archive ?
In the TEG functional fibrinogen test, the tissue factor is used for coagulation activation described classically as extrinsic, with the platelet function inhibited by ReoPro (abciximab, Eli Lilly and Company, Indianapolis, Indiana), a GPIIb/IIIa inhibitor, so the resulting contribution of the functional fibrinogen to clot strength can be viewed.
I am fairly comfortable with medications related to ischemic strokes (tpa, reopro, heparin, blood pressure medication, antilipids, blood glucose management, etc.
The primary endpoint was designed to show a 40% decline in bleeding events with ALX-0081 compared with ReoPro, but results showed that there was no statistically significant difference between the total number of bleeding events for the two compounds.
The hemiparesis was resolved by Reopro bolus and subsequent infusion.
Because of residual clot, the IIb/IIIa inhibitor, ReoPro, was given, and discontinued the same day.
VerifyNow is a rapid, simple, and accurate system for measuring individual response to every major antiplatelet medication, including aspirin, Plavix, ReoPro, and Integrilin.
s major products include Prozac (an antidepressant), Axid (antiulcer), Kefzol, Ceclor, Lorabid (antibiotics), Zyprexa (schizophrenia), Humatrope (human growth hormone), Humulin (insulin), Reopro (angioplasty) and Evista (osteoporosis).
The list of these "silver bullets" now includes Herceptin for a type of breast cancer, Rituxan for a type of lymphoma, ReoPro for clot prevention during coronary artery intervention, and Remicade for Crohn's disease.
Angioplasty patients at 100 Top hospitals were significantly more likely to be treated with stents and expensive new drugs like Reopro and Integrelin than their counterparts at average hospitals, Chenoweth quotes still another Solucient data analysis.
Stenting made a huge improvement, as did the addition of certain drugs like ReoPro.
ENTIRE (ENoxaparin and TNK-tPA with or without GP IIb/IIIa Inhibitor as REperfusion strategy in ST elevation MI), also referred to as TIMI 23, will examine TIMI flows through coronary angiography, utilizing varying dosing regimens of TNKase(TM) (Tenecteplase), the low-molecular-weight heparin Lovenox, the anti-platelet agent ReoPro, and heparin sodium.